Skip to main content
logo
Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
40.30
-1.88 (-4.46%)
At close: Nov 5, 2026, 4:00 PM EST
40.07
-0.23 (-0.57%)
After-hours: Nov 5, 2026, 7:59 PM EST

Revenue

Millions DKK. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20
Ozempic Pill / Rybelsus Revenue
4.94B
Ozempic Injectable Revenue
29.71B
Victoza Revenue
105.00M
Total GLP-1 Revenue
34.75B
Long-Acting Insulin Revenue
4.38B
Premix Insulin Revenue
2.42B
Fast-Acting Insulin Revenue
4.38B
Human Insulin Revenue
1.09B
Total Insulin Revenue
12.27B
Other Diabetes Care Revenue
531.00M
Total Diabetes Care Revenue
47.55B
Wegovy Injectable Revenue
20.41B
Wegovy Pill Revenue
5.39B
Saxenda Revenue
345.00M
Total Obesity Care Revenue
26.15B
Diabetes & Obesity Care Revenue
73.69B
Rare Blood Disorders Revenue
3.06B
Rare Endocrine Disorders Revenue
1.99B
Other Rare Disease Revenue
455.00M
Rare Disease Revenue
5.50B
Revenue (Total)
79.20B

Revenue by Geography

Millions DKK. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20
US Revenue
41.88B
EUCAN Revenue
19.86B
Emerging Markets Revenue
7.38B
APAC Revenue
5.04B
China Revenue
5.03B
Total International Revenue
37.32B
Revenue (Other)
-37.32B
Revenue (Total)
79.20B

EBIT

Millions DKK. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20
Diabetes & Obesity Care Operating Profit
21.57B
Rare Disease Operating Profit
1.44B
Operating Income (Total)
23.01B